{"title":"Tranexamic Acid Injections, Tablets \u0026 IV Solutions","description":"\u003ch1\u003eTranexamic Acid\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eTranexamic acid injection is a prescription antifibrinolytic agent (a “clot-stabilizing” drug). Its active ingredient, tranexamic acid, is an amino acid that helps slow down bleeding by blocking the breakdown of blood clots. Normally, when the body is bleeding, it forms clots made of fibrin to stop the bleeding. The fibrin clots are gradually dissolved by a natural process called \u003cem\u003efibrinolysis\u003c\/em\u003e, which involves an enzyme called plasmin. Tranexamic acid inhibits plasminogen (the precursor to plasmin), preventing fibrin clots from being broken down too quickly. In effect, it allows clots to stay in place longer and reduces ongoing bleeding without causing new clots to form on its own.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTranexamic Acid Injection \u0026amp; IV Solution\u003c\/strong\u003e (TXA) are advanced, prescription hospital medications designed for rapid, effective control of acute bleeding and life-threatening hemorrhage. Widely used in trauma centers, surgery rooms, emergency departments, and obstetric units, Tranexamic Acid IV halts excessive blood loss by stabilizing blood clots. TXA is the gold standard for trauma bleeding, postpartum hemorrhage, dental procedures, heavy menstrual bleeding, and major surgical operations. Choose Tranexamic Acid Injection for safe, fast-acting blood loss management, improved surgical outcomes, and superior patient recovery.\u003c\/p\u003e\n\u003ch2\u003eUses (Indications)\u003c\/h2\u003e\n\u003cp\u003eTranexamic acid injection is given intravenously to \u003cstrong\u003etreat or prevent excessive bleeding\u003c\/strong\u003e in various medical situations:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMenorrhagia (heavy menstrual bleeding):\u003c\/strong\u003e Can be used intraoperatively during gynecologic surgeries or in severe cases of menstrual bleeding (though oral forms are more common for routine periods).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical bleeding:\u003c\/strong\u003e Used prophylactically or as needed during\/after major surgeries (cardiac, orthopedic, liver, obstetric, dental, etc.) to reduce blood loss. For example, it is often given during cardiac bypass, orthopaedic joint replacement, or cesarean delivery (postpartum hemorrhage) to lessen bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrauma and acute bleeding:\u003c\/strong\u003e (Off-label) It may be used in trauma protocols (Massive Transfusion, e.g. CRASH-2 trial in trauma) to reduce bleeding. It’s also given when bleeding is due to dissolution of clots (e.g. after tPA treatment).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther hemorrhagic conditions:\u003c\/strong\u003e Such as bleeding from the nose\/mouth, gastrointestinal bleeding, or bleeding following prostate\/urinary tract surgery, where stabilizing clots can help. It is also an adjunct in hemophilia patients undergoing dental extractions [6†L39-L47].\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsumptive coagulopathies:\u003c\/strong\u003e In some cases of disseminated intravascular coagulation (DIC) with hyperfibrinolysis, tranexamic acid can be used, but only under strict specialist guidance (because DIC involves complex clotting issues).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn summary, tranexamic acid injection is used whenever an experienced physician judges that preventing fibrin clot breakdown will safely control undesirable bleeding.\u003c\/p\u003e\n\u003ch3\u003ePurpose\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTranexamic Acid Injection \u0026amp; IV Solution\u003c\/strong\u003e are formulated to rapidly prevent and control severe, acute bleeding in trauma, surgical, obstetric, and dental emergencies. TXA works by blocking the breakdown of blood clots, stabilizing hemostasis, and reducing the risk of death or complications from hemorrhage.\u003c\/p\u003e\n\u003ch3\u003eUses\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrauma Care:\u003c\/strong\u003e Life-saving first-line therapy for acute traumatic hemorrhage in accident victims and emergency scenarios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical Procedures:\u003c\/strong\u003e Reduces intraoperative and postoperative blood loss in major surgeries (cardiac, orthopedic, ENT).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePostpartum Hemorrhage:\u003c\/strong\u003e Critical management of heavy bleeding after childbirth; recommended by WHO for maternal safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHeavy Menstrual Bleeding:\u003c\/strong\u003e Rapid treatment for acute menorrhagia when oral therapy is insufficient.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDental Surgery:\u003c\/strong\u003e Controls bleeding during and after dental extractions, especially in patients with bleeding disorders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLiver Cirrhosis and Coagulopathy:\u003c\/strong\u003e Supportive management in selected coagulation disorders as directed by specialists.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTypes \u0026amp; Formulations\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTranexamic Acid Injection (IV\/IM):\u003c\/strong\u003e Sterile solution for intravenous or intramuscular use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use IV Bags:\u003c\/strong\u003e Pre-mixed solutions for fast infusion in emergency and operative settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh-Concentration Vials:\u003c\/strong\u003e For dilution and dose customization in critical care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003ePopular Brands\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eCyklokapron® (Pfizer)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eTransamin® (Daiichi Sankyo)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHemtran®\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eLysteda® (oral, for reference)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGeneric TXA Injection (Fresenius Kabi, Hikma, Amneal, Teva)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSandoz Tranexamic Acid Injection\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eStrengths\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003e100 mg\/mL\u003c\/strong\u003e (most common hospital and surgical strength)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e500 mg\/5 mL\u003c\/strong\u003e ampules or vials\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e1 g\/10 mL\u003c\/strong\u003e vials\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003ePre-mixed 1 g\/100 mL IV bags\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdjustable by body weight\/clinical need\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSizes\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e5 mL, 10 mL single-dose ampules or vials\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e100 mL, 250 mL ready-to-infuse IV bags\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eBulk packs for trauma, surgery, and emergency rooms\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eConvenient, single-use formats for field and ambulance use\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eTranexamic acid is \u003cstrong\u003eadministered by slow intravenous injection (IV)\u003c\/strong\u003e or \u003cstrong\u003eIV infusion\u003c\/strong\u003e. It should \u003cstrong\u003eonly be given by or under supervision of healthcare providers\u003c\/strong\u003e. The solution commonly comes as 100 mg\/mL (for example, 500 mg in 5 mL, as noted on the UK product label). Before injection, the skin and vein access are prepared using standard aseptic technique.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e The exact dose depends on the clinical situation and patient’s size:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eA typical adult dose is \u003cstrong\u003e1,000 mg (10 mL of 100 mg\/mL) IV every 6–8 hours\u003c\/strong\u003e while bleeding continues. This corresponds to about \u003cem\u003e15 mg per kg of body weight\u003c\/em\u003e per dose (up to ~4–5 doses per day).\u003c\/li\u003e\n\u003cli\u003eIn surgical or acute settings, 10–15 mg\/kg IV over 10–20 minutes is often used. For example, a heart surgery protocol might use 10–15 mg\/kg IV before incision, sometimes followed by additional doses or infusion.\u003c\/li\u003e\n\u003cli\u003eFor severe bleeding or trauma, an initial bolus (e.g. 1–2 g IV) may be given, followed by continuous infusion as per trauma protocols (some guidelines recommend a total of ~3 g over 24 hours). (Recent studies have shown benefit in trauma when given early.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChildren:\u003c\/strong\u003e Doses are weight-based. For example, a child bleeding severely might receive about 10–15 mg\/kg IV every 6–8 hours. Oral dosing is an option for less acute situations (liquid or tablets), but the question specifically addresses injection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal impairment:\u003c\/strong\u003e Dosage should be reduced in moderate-to-severe kidney failure (since tranexamic acid is excreted by the kidneys). Elderly patients and those with kidney issues typically require dose adjustment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Tranexamic acid must be given \u003cstrong\u003eslowly\u003c\/strong\u003e. A rapid IV push can cause hypotension. The patient information leaflet states: \u003cem\u003e“Tranexamic Acid Solution for Injection should only be administered slowly into a vein.”\u003c\/em\u003e. Never inject it into a muscle or skin. Use infusion pumps or slow push over 10–20 minutes if needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eAll doses and frequency are determined by the treating physician based on bleeding severity and patient factors. The medication is usually given in a hospital or clinical setting with vital sign monitoring.\u003c\/p\u003e\n\u003ch2\u003eSide Effects and Precautions\u003c\/h2\u003e\n\u003cp\u003eBecause tranexamic acid affects clot stability, certain side effects and cautions apply:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClotting risk:\u003c\/strong\u003e Theoretically, anything that stabilizes clots could increase clot risk. In practice, serious clotting events (thrombosis) are \u003cstrong\u003erare\u003c\/strong\u003e with tranexamic acid, but the drug is \u003cstrong\u003econtraindicated\u003c\/strong\u003e in patients who have active intravascular clots or a history of conditions that predispose to clots (deep vein thrombosis, pulmonary embolism, cerebral thrombosis, etc.). It should be used with caution in patients with risk factors for thrombosis (e.g. smoking, pregnancy, estrogen use) and not at all if they have DIC (systemic clotting) or a history of arterial clots. Reportedly, rare cases of stroke or blood clots have occurred, so it is crucial that bleeding is due to high fibrinolysis (breakdown) and not normal clotting. If any clot-related symptoms (limb pain\/swelling, chest pain, neurological deficit) occur, treatment must stop and medical evaluation is needed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAllergic reactions:\u003c\/strong\u003e Some people can be allergic to tranexamic acid. Symptoms of allergy include rash, itching, hives, difficulty breathing, or swelling of face\/lips.. True anaphylaxis is very rare but has been reported. If any sign of allergy appears during the injection, it should be stopped immediately.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHypotension:\u003c\/strong\u003e Rapid injection of tranexamic acid can cause a sudden drop in blood pressure. Always inject slowly with the patient lying down or closely monitored to avoid this. If hypotension occurs, support blood pressure as needed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNeurological:\u003c\/strong\u003e High doses or very rapid infusion may cause seizures (convulsions). Therefore, the lowest effective dose should be used. The UK leaflet specifically warns: “Tranexamic acid solution should not be administered [IV] if you have a history of convulsions…Your doctor must use the minimal dose possible to avoid convulsions.”. Rarely, visual disturbances have been reported (blurry vision or color changes), especially with long-term use. If vision problems occur, the drug should be discontinued and an ophthalmologist consulted.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther side effects:\u003c\/strong\u003e Common side effects may include nausea, vomiting, diarrhea, or abdominal discomfort. These are usually mild. Less common effects include headache or dizziness. Very rarely, patients may develop muscle spasms (related to altered amino acid levels). The patient leaflet also lists rare effects like joint or muscle pain. In research trials, serious side effects beyond those noted above were uncommon.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRenal caution:\u003c\/strong\u003e Since tranexamic acid is excreted by the kidneys, those with impaired renal function need dose adjustments (as above). In kidney failure, accumulation may increase seizure risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOther precautions:\u003c\/strong\u003e Tell your doctor if you have any problems with blood clotting, if you have a history of eye disease, or neurological conditions. Tranexamic acid can interact with other drugs, particularly clotting factors or thrombolytics: it is \u003cstrong\u003econtraindicated\u003c\/strong\u003e with prothrombin complex concentrate or factor IX products (risk of clot). Also, if you take hormonal birth control or estrogen, mention it because both can modestly increase clot risk, although the combination is not absolutely contraindicated (but caution is advised).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIn case of overdose, symptoms would mainly be hypotension or clotting issues. There is no specific antidote, so treatment is symptomatic and supportive (manage blood pressure, watch kidney function, etc.).\u003c\/p\u003e\n\u003ch2\u003eKey Points and Safe Use\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTranexamic acid injection\u003c\/strong\u003e (often known by the brand Cyklokapron) is used to \u003cem\u003eprevent or reduce bleeding\u003c\/em\u003e by blocking the breakdown of clots. It’s given \u003cstrong\u003eintravenously\u003c\/strong\u003e by trained professionals only (e.g. during surgery or heavy bleeding events).\u003c\/li\u003e\n\u003cli\u003eIt is commonly dosed at \u003cstrong\u003e1 gram IV slowly every 6–8 hours\u003c\/strong\u003e (or 15 mg\/kg per dose) for adults, depending on the situation. Pediatric doses are weight-based (about 10–15 mg\/kg). Always double-check dosing, especially in children or kidney-impaired patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWatch for clots:\u003c\/strong\u003e The main risk is unwanted thrombosis. Avoid using it in patients who have active clots, DIC, or serious risk of clots. Monitor for any sign of clot (leg pain\/swelling, breathing trouble, chest pain).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAllergy:\u003c\/strong\u003e Rare severe allergic reactions can occur. Be ready to treat anaphylaxis if needed (oxygen, epinephrine, etc.) when giving any IV medication.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e Inject \u003cstrong\u003eslowly\u003c\/strong\u003e (generally over 10 minutes or via infusion pump). Rapid injection can cause dangerous hypotension. Do not inject into muscle or elsewhere besides a vein. Always use aseptic technique and properly dispose of needles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLater effects:\u003c\/strong\u003e Inform your doctor of any change in vision or severe headache during therapy. Long-term use (if ever needed) requires eye exams and watching for visual changes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cem\u003eDisclaimer: I am not a doctor. The information below is for general knowledge and not medical advice. Always follow a healthcare provider’s directions.\u003c\/em\u003e\u003c\/span\u003e\u003c\/p\u003e","products":[{"product_id":"tranexamic-acid-for-injection-1-000-mg-10-ml-injection-single-dose-vial-10-ml-x10-box","title":"Provepharm Tranexamic Acid (TXA) for Injection Single-Dose Vial 10 mL x 10\/Box (Rx)","description":"\u003cp\u003eProvepharm Tranexamic Acid for Injection 100 mg\/10 mL Injection Single-Dose Vial 10 mL. An injectable form of tranexamic acid is available which is used to improve the surgical outcome in patients with heavy blood loss. Tranexamic acid is a weak fibrinolytic agent that competitively inhibits plasminogen activation, and thereby diminishes the degradation of fibrinogen, plasminogen, and fibrin.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits of Using Tranexamic Acid (TXA) for Injection\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEfficient at regulating and reducing excessive bleeding caused by trauma, surgery, or spontaneous haemorrhage\u003c\/li\u003e\n\u003cli\u003eFaster onset of action than oral formulation\u003c\/li\u003e\n\u003cli\u003eLess risk of adverse events compared to oral route\u003c\/li\u003e\n\u003cli\u003eConvenient and easy to use single-dose vial of 10 mL\u003c\/li\u003e\n\u003cli\u003eEnhanced patient compliance due to convenient dosing\u003c\/li\u003e\n\u003cli\u003eReduce the need for blood transfusions associated with trauma and surgery\u003c\/li\u003e\n\u003cli\u003eReduces mortality in heavy trauma patients\u003c\/li\u003e\n\u003cli\u003eMinimizes hospital stay and associated costs\u003c\/li\u003e\n\u003cli\u003eSafe and effective in both adult and pediatric patients\u003c\/li\u003e\n\u003cli\u003eHigh patient satisfaction with the results\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranexamic Acid (TXA) for Injection Injection Single-Dose Vial 10 mL is a blood-clotting medication that is used to treat and prevent excessive bleeding. It works by stopping the breakdown of blood clots which helps minimize the amount of blood lost during surgery or trauma. Tranexamic Acid Injection helps keep clotting factors in balance thus making it an effective option for trauma victims who experience severe bleeding. Studies have also confirmed that the Tranexamic Acid Injection is effective in reducing risk of death due to bleeding in trauma patients. It is thus an important medical tool for trauma victims and is often used both before as well as during surgery or trauma. Tranexamic Acid Injection can be very useful in helping trauma victims with extensive bleeding.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003cstrong\u003eInstructions on How To Use Provepharm Tranexamic Acid for Injection\u003c\/strong\u003e \u003cbr data-mce-fragment=\"1\"\u003e1. Read all instructions before using Provepharm Tranexamic Acid (TXA) for Injection.\u003cbr data-mce-fragment=\"1\"\u003e2. In preparation for performing the injection, disinfect the intended injection site.\u003cbr data-mce-fragment=\"1\"\u003e3. Remove the Sealing Ring and Stopper from the Single-Dose Vial of Provepharm Tranexamic Acid (TXA) for Injection.\u003cbr data-mce-fragment=\"1\"\u003e4. Using aseptic technique, attach a sterile needle and a sterile syringe to the Single-Dose Vial of Provepharm Tranexamic Acid (TXA) for Injection.\u003cbr data-mce-fragment=\"1\"\u003e5. Draw out the required dosage of Provepharm Tranexamic Acid (TXA) for Injection into the sterile syringe.\u003cbr data-mce-fragment=\"1\"\u003e6. Remove the needle and syringe from the Vial.\u003cbr data-mce-fragment=\"1\"\u003e7. Attach a new, sterile needle to the syringe.\u003cbr data-mce-fragment=\"1\"\u003e8. Inject Provepharm Tranexamic Acid (TXA) for Injection into the desired intramuscular, intravenous, or subcutaneous injection site.\u003cbr data-mce-fragment=\"1\"\u003e9. Dispose of all used needles and syringes per local regulations.\u003cbr data-mce-fragment=\"1\"\u003e10. After using Proveph\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr\u003eThe mechanism of action of tranexamic acid for injection is considered to be the inhibition of plasminogen activation and, as a consequence, a decrease in degradation of fibrinogen, plasminogen, and fibrin.\u003c\/p\u003e\n\u003cp\u003eBuy Tranexamic Acid for Injection 1,000 mg online at Mountainside Medical Equipment.\u003c\/p\u003e","brand":"Provepharm Inc","offers":[{"title":"Default Title","offer_id":39947885445192,"sku":"81284-0611-10","price":125.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Provepharm-Tranexamic-Acid-_TXA_-for-Injection-Single-Dose-Vial-10-mL.jpg?v=1715345051"},{"product_id":"armas-tranexamic-acid-for-injection-1-000-mg-10-ml-injection-single-dose-vial-10-ml-x10-box","title":"Tranexamic Acid Injection 1000 mg Vial 10 mL x 10\/Box (Rx)","description":"\u003cp\u003eTake command of acute bleeding fast with Tranexamic Acid Injection 1000 mg\/10 mL Vial (10 mL) from Armas Pharmaceuticals—the trusted, hospital-grade, antifibrinolytic solution for trauma hemorrhage, emergency bleeding management, and perioperative blood loss reduction. This high-concentration, ready-to-use injectable vial provides essential support for trauma rooms, operating rooms, ICUs, and emergency carts everywhere.\u003c\/p\u003e\n\u003ch2\u003eFeatures \u0026amp; Health Benefits\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRapid Bleeding Control:\u003c\/strong\u003e Potent antifibrinolytic therapy that inhibits fibrinolysis, helping stabilize clots and reduce excessive blood loss fast.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCritical Trauma and Surgical Essential:\u003c\/strong\u003e Indicated for acute control of severe trauma bleeding, major surgery, cesarean section hemorrhage, postpartum hemorrhage, and GI bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVersatile Emergency Hemostatic Agent:\u003c\/strong\u003e Standard of care for trauma teams, surgical suites, and ERs—suitable for both adult and pediatric protocols.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh-Concentration, Ready-to-Administer Vial:\u003c\/strong\u003e Each vial delivers 1000 mg of tranexamic acid in a 10 mL (100 mg\/mL) solution for IV infusion or slow injection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved, High-Quality Manufacturing:\u003c\/strong\u003e Produced by \u003cem\u003eArmas Pharmaceuticals\u003c\/em\u003e—a leader in reliable, sterile injectable medications for hospital and emergency use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCrash Cart \u0026amp; Field-Ready:\u003c\/strong\u003e Trusted for inclusion in medication kits for mass casualty events, ambulances, and disaster response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eUses \u0026amp; Clinical Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eHemorrhagic trauma \/ major trauma bleeding\u003c\/li\u003e\n\u003cli\u003ePostpartum hemorrhage \/ obstetric bleeding\u003c\/li\u003e\n\u003cli\u003ePerioperative blood loss in surgery\u003c\/li\u003e\n\u003cli\u003eDental, cardiac, orthopedic, and spinal surgery\u003c\/li\u003e\n\u003cli\u003eGastrointestinal bleeding (GI bleed)\u003c\/li\u003e\n\u003cli\u003eNosebleeds (epistaxis), hematuria, and other acute bleeding events\u003c\/li\u003e\n\u003cli\u003eHemophilia and clotting disorders (as directed)\u003c\/li\u003e\n\u003cli\u003eFirst-line for uncontrolled bleeding in emergency and critical care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWhy Choose Tranexamic Acid Injection by Armas Pharmaceuticals?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFast-acting, easy-to-dose, and reliable\u003c\/strong\u003e—minimizes time-to-treatment in severe blood loss scenarios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompatible with all standard IV protocols\u003c\/strong\u003e—simply draw up and administer, no diluting required.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBacked by proven clinical research\u003c\/strong\u003e—included in major trauma and surgery guidelines for improved patient outcomes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUniversal in trauma \u0026amp; code carts\u003c\/strong\u003e—hospital, field, and ambulatory care ready.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHigh stability \u0026amp; extended shelf life\u003c\/strong\u003e for guaranteed potency when you need it most.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eTop Search Terms for Tranexamic Acid Injection\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eTranexamic acid injection 1000 mg\/10 mL\u003c\/li\u003e\n\u003cli\u003eEmergency bleeding control IV\u003c\/li\u003e\n\u003cli\u003eTrauma hemorrhage treatment\u003c\/li\u003e\n\u003cli\u003eAntifibrinolytic injection hospital\u003c\/li\u003e\n\u003cli\u003eSurgery blood loss reduction medication\u003c\/li\u003e\n\u003cli\u003eRapid hemorrhage management drug\u003c\/li\u003e\n\u003cli\u003eTranexamic acid vial Armas Pharmaceuticals\u003c\/li\u003e\n\u003cli\u003eCritical care hemostasis injection\u003c\/li\u003e\n\u003cli\u003ePostpartum hemorrhage IV treatment\u003c\/li\u003e\n\u003cli\u003eMassive blood loss trauma medicine\u003c\/li\u003e\n\u003cli\u003eGI bleed emergency injection\u003c\/li\u003e\n\u003cli\u003eBest hospital antifibrinolytic agent\u003c\/li\u003e\n\u003cli\u003eCrash cart bleeding medication\u003c\/li\u003e\n\u003cli\u003eHemophilia bleeding control IV\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDirections for Use\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e For intravenous (IV) infusion or slow IV injection only.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdult dosing:\u003c\/strong\u003e Standard is 1,000 mg (10 mL) IV, may repeat or infuse as per trauma, surgery, or OB protocol.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePediatric dosing:\u003c\/strong\u003e Per physician instruction—frequently weight-based.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHow to administer:\u003c\/strong\u003e\n\u003col\u003e\n\u003cli\u003eInspect vial for particulates or discoloration.\u003c\/li\u003e\n\u003cli\u003eDraw dose using sterile syringe.\u003c\/li\u003e\n\u003cli\u003eAdminister via slow IV push or diluted IV infusion as directed.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/li\u003e\n\u003cli\u003eAlways follow facility and evidence-based protocols for dosing and infusion rate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCommon:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea, vomiting, diarrhea\u003c\/li\u003e\n\u003cli\u003eInjection site reactions\u003c\/li\u003e\n\u003cli\u003eHeadache, muscle pain\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSerious (Seek Immediate Help):\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eVisual disturbances, blurred vision or color vision changes\u003c\/li\u003e\n\u003cli\u003eSeizures\u003c\/li\u003e\n\u003cli\u003eSigns of blood clots (pain, swelling, chest pain, shortness of breath)\u003c\/li\u003e\n\u003cli\u003eAllergic reactions: rash, itching, swelling, trouble breathing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote\u003e\n\u003cp\u003e\u003cem\u003eRegular monitoring for adverse effects is advised, especially in patients with history of thrombosis, renal impairment, or seizure disorders.\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eUse in monitored medical settings only.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eAvoid use in patients with active thromboembolic disease, history of seizures, or hypersensitivity to tranexamic acid.\u003c\/li\u003e\n\u003cli\u003eDose adjustments may be needed in renal impairment.\u003c\/li\u003e\n\u003cli\u003eMonitor vision, coagulation status, and renal function as per protocol.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eFor fast, reliable control of severe bleeding in trauma, surgery, or emergency care, trust Tranexamic Acid Injection 1000 mg\/10 mL Vial by Armas Pharmaceuticals—hospital and EMS gold-standard for life-saving hemorrhage management and improved patient survival.\u003c\/span\u003e\u003c\/p\u003e","brand":"Armas Pharmaceuticals","offers":[{"title":"Default Title","offer_id":39947887280200,"sku":"72485-0510-10P","price":69.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tranexamic-Acid-_TXA_-for-Injection-1000-mg-by-Armas-Pharmaceuticals-72485-0510-10.jpg?v=1744747679"},{"product_id":"exela-tranexamic-acid-in-sodium-chloride-iv-bags-1-000-mg-100-ml-iv-bags-10-case","title":"IV Bags, Tranexamic Acid (TXA) in Sodium Chloride 0.7% Solution 1,000 mg\/100 mL 10\/Case","description":"\u003cp\u003eTranexamic acid (TXA) is a synthetic lysine analogue that competitively inhibits the lysine-binding sites of plasminogen, thereby blocking the conversion of plasminogen to plasmin. TXA has anti-fibrinolytic and anti-inflammatory properties.TXA is used to treat or prevent excessive bleeding, including dental extraction bleeding, menorrhagia, and postpartum hemorrhage.TXA is also used off-label to improve surgical outcomes, including reducing the incidence of post-operative blood transfusions and cardiac events.TXA is available in intravenous (IV) and oral formulations.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBenefits for Using Exela Tranexamic Acid in Sodium Chloride 0.7% IV Bags\u003c\/strong\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eReduces bleeding and clotting time, resulting in faster wound healing.\u003c\/li\u003e\n\u003cli\u003eMinimizes damage to tissue around the wound, promoting the growth of healthy, new tissue.\u003c\/li\u003e\n\u003cli\u003eAcceleres recovery time and reduces need for blood transfusions.\u003c\/li\u003e\n\u003cli\u003eEffectively treats and prevents deep vein thrombosis and pulmonary emboli.\u003c\/li\u003e\n\u003cli\u003eProvides effective pain control related to injury and surgery.\u003c\/li\u003e\n\u003cli\u003eCan be administered quickly and easily via intravenous infusion one bag at a time.\u003c\/li\u003e\n\u003cli\u003eEasy to adjust dosage frequency for different patients and treatment purposes.\u003c\/li\u003e\n\u003cli\u003eCost-effective when compared to other anti-bleed drug regimens.\u003c\/li\u003e\n\u003cli\u003eRelatively free of side effects when administered appropriately.\u003c\/li\u003e\n\u003cli\u003eThusa, reducing the risks of complications associated with delayed or inadequate treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranexamic Acid in Sodium Chloride 0.7% IV bags provides clinical potential for a number of medical applications with specific outcome goals. The exela IV bag measures 1000 mg per 100mL multiplying 0.7% sodium chloride v\/v as the injection form into RNA Solutions used in a closed clinical setting. It is indicated for controlling excessive urinary bleeding and treating complex orthopedic occurrences due to severe trauma, has swap and substitution properties extending it to varied THR operations and more. An additional preventative outcome are the stop the cycle TXA uses, providing Hematuria control and Post operative Hyperfibrinolyis inhibition by Initial doses above 1-2500mg recommended, and endorsed after every 6 hours since then with careful instructions my doctor. Its cost factor has seen it emerger in many formulations with unrivaled performance and proven clinical safety as a favorable Tranexamic Acid in Sodium Chloride 0.7% IV Bag transmission but most encampasses a hemolytic cryoprecipitate precipitates diluted solution with excellence results.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eInstructions on How to Use  Exela Tranexamic Acid in Sodium Chloride 0.7% IV Bags\u003c\/strong\u003e\u003cbr\u003e1. Read the entire instructions on the package before administering Exela Tranexamic Acid (TXA) in Sodium Chloride\u003cbr\u003e0.7% IV Bags.\u003cbr\u003e2. Fill a sterile IV bag with 100 ml of Sodium Chloride 0.7 % sterile IV bags and add 10 grams of Exela Tranexamic Acid combined in the IV bag.\u003cbr\u003e3. Thoroughly shake or mix the saline quality of the sodium chloride and Exela Tranexamic Acid solution after removing it from the sterile IV bag until the medicine is dissolved in the solution completely.\u003cbr\u003e4. Secure IV lines and connections properly before and during the infusion of Exela Tranexamic Acid.\u003cbr\u003e5. Dilute or constitute Exela Trananeamic Acid and sodium chloride solution if needed as per healthcare provider suggestions.\u003cbr\u003e6. Check the Exela Tranexamic Acid prepared solution for purity, particles or discoloration before administering it intravenously.\u003cbr\u003e7. Administer the magical Exela Tranexamic Acid solution in the patient's vein in case of slowly flowing intravenous injection through infusion line of set under the guidance of the healthcare provider.\u003cbr\u003e8. Record patient's vital signs frequently and regularly during and after slowly administering the Exela Tranexamic Acid solution intravishly.\u003cbr\u003e9. Stop the infusion of solution into the patient if vomiting, nausea, rashes or infection appears during the intravenous injection and inform healthcare provider immediately.\u003cbr\u003e10. Check for any hypersensitivity or damage to the patient due to Exela Tranexamic Acid with the help of healthcare provider.\u003c\/p\u003e\n\u003cp\u003e\u003cbr data-mce-fragment=\"1\"\u003eThe mechanism of action of TXA in reducing blood loss during and after surgery is multifactorial. It has been shown to reduce platelet activation, thrombin generation, and fibrin degradation.TXA also has anti-inflammatory effects, which may minimize tissue damage and inflammation-induced blood loss. In addition, TXA is a potent inhibitor of plasmin, the enzyme responsible for fibrin degradation. By blocking the conversion of plasminogen to plasmin, TXA reduces the amount of fibrin degradation products, and ultimately the amount of bleeding.\u003c\/p\u003e","brand":"Exela Pharma Sciences","offers":[{"title":"Default Title","offer_id":39947889639496,"sku":"51754-0108-03","price":295.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Exela-Tranexamic-Acid-in-Sodium-Chloride-IV-Bags.jpg?v=1683290459"},{"product_id":"pfizer-cyklokapron-tranexamic-acid-ampules-for-injection-1-000-mg-10-ml-single-dose-vial-10-ml","title":"Cyklokapron Tranexamic Acid (TXA) Ampule Injection 1,000 mg\/10 mL Vial 10 mL by Pfizer (Rx)","description":"\u003cp\u003ePfizer Cyklokapron Tranexamic Acid (TXA) Ampules for Injection. An injectable form of tranexamic acid is available which is used to improve the surgical outcome in patients with heavy blood loss. Tranexamic acid is a weak fibrinolytic agent that competitively inhibits plasminogen activation, and thereby diminishes the degradation of fibrinogen, plasminogen, and fibrin.\u003c\/p\u003e\n\u003cp\u003eCyklokapron (Tranexamic acid) is a drug that inhibits the breakdown of fibrinogen, a protein in the blood that helps with clotting. Cyklokapron is used to treat heavy menstrual bleeding and bleeding after childbirth. Cyklokapron is available as a tablet and an injection.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eWhat are the benefits of taking Cyklokapron?\u003cbr data-mce-fragment=\"1\"\u003eCyklokapron can help to reduce menstrual bleeding by up to 80%. It can also help to reduce the amount of blood lost after childbirth by up to 50%. Cyklokapron works by stopping the breakdown of fibrinogen, a protein in the blood that is important for clotting. This can help to reduce the risk of heavy bleeding.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eCYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39947896946760,"sku":"00013-1114-15","price":49.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/PfizerCyklokapronTranexamicAcidAmpulesforInjection.jpg?v=1683293350"},{"product_id":"pfizer-cyklokapron-tranexamic-acid-for-injection-1-000-mg-10-ml-single-dose-vial-10-ml-x-10-box","title":"Cyklokapron Tranexamic Acid for Injection 1000 mg\/10 mL Single-dose Vial 10 mL x 10\/Box by Pfizer (RX)","description":"\u003cp\u003eCyklokapron Tranexamic Acid for Injection. An injectable form of tranexamic acid is available which is used to improve the surgical outcome in patients with heavy blood loss. Tranexamic acid is a weak fibrinolytic agent that competitively inhibits plasminogen activation, and thereby diminishes the degradation of fibrinogen, plasminogen, and fibrin.\u003c\/p\u003e\n\u003cp\u003eCyklokapron (Tranexamic acid) is a drug that inhibits the breakdown of fibrinogen, a protein in the blood that helps with clotting. Cyklokapron is used to treat heavy menstrual bleeding and bleeding after childbirth. Cyklokapron is available as a tablet and an injection.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003eWhat are the benefits of taking Cyklokapron?\u003cbr data-mce-fragment=\"1\"\u003eCyklokapron can help to reduce menstrual bleeding by up to 80%. It can also help to reduce the amount of blood lost after childbirth by up to 50%. Cyklokapron works by stopping the breakdown of fibrinogen, a protein in the blood that is important for clotting. This can help to reduce the risk of heavy bleeding.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eCYKLOKAPRON® is indicated in patients with hemophilia for short-term use (2 to 8 days) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction.\u003c\/p\u003e","brand":"Pfizer USPG","offers":[{"title":"Default Title","offer_id":39947915165768,"sku":"00013-1114-21","price":269.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Cyklokapron-Tranexamic-Acid--for-Injection-1000-mg.jpg?v=1765213084"},{"product_id":"xgen-tranexamic-acid-txa-for-injection-100-mg-injection-single-dose-vial-10-ml-x-10-box","title":"Tranexamic Acid (TXA) for Injection 100 mg Injection Single-Dose Vial 10 mL x 10\/Box (Rx)","description":"\u003cp\u003eTranexamic Acid (TXA) for injection is used to prevent or reduce bleeding in various medical situations. It works by inhibiting the breakdown of blood clots, helping to maintain hemostasis. TXA is commonly used in:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical Procedures\u003c\/strong\u003e: To reduce bleeding during and after surgeries, such as orthopedic, cardiac, or dental surgeries.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrauma Cases\u003c\/strong\u003e: To control acute bleeding in trauma patients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMenorrhagia\u003c\/strong\u003e: To treat heavy menstrual bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePerioperative Care\u003c\/strong\u003e: In certain procedures where blood loss is a concern, such as in patients with hemophilia.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eIt's important to use TXA under medical supervision, as its administration involves specific dosage and timing considerations depending on the condition being treated.\u003c\/p\u003e\n\u003cp\u003eXgen Pharma's Tranexamic Acid for Injection is a high-quality hemostatic agent designed to effectively reduce bleeding in a variety of clinical settings. Trusted by healthcare professionals, TXA is a critical tool in the management of hemorrhage, providing reliable and consistent performance.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 100 mg of Tranexamic Acid per 10 mL vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e Single-dose vials, 10 vials per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality Assurance:\u003c\/strong\u003e Manufactured under strict quality control standards to ensure safety and efficacy\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurpose:\u003c\/strong\u003e Commonly used in surgical procedures, trauma, and other instances of excessive bleeding\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompatibility:\u003c\/strong\u003e Can be combined with other hemostatic agents under professional guidance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid inhibits fibrinolysis by competitively blocking the lysine-binding sites on plasminogen, which prevents the conversion of plasminogen to plasmin. This process stabilizes clots and reduces bleeding by maintaining the clot structure.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eDosage and Administration:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdminister intravenously as prescribed by a healthcare professional.\u003c\/li\u003e\n\u003cli\u003eDosage and duration depend on the condition being treated.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePreparation:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eInspect vials for particulate matter and discoloration prior to administration.\u003c\/li\u003e\n\u003cli\u003eFollow aseptic techniques for preparation and administration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStorage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStore at controlled room temperature (20°C to 25°C or 68°F to 77°F).\u003c\/li\u003e\n\u003cli\u003eProtect from light and do not freeze.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnaphylactic Reactions:\u003c\/strong\u003e May occur; have emergency equipment and treatment available.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThromboembolic Risk:\u003c\/strong\u003e Use cautiously in patients with a history of thromboembolic disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Impairment:\u003c\/strong\u003e Dosage adjustment may be necessary for patients with kidney issues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVisual Disturbances:\u003c\/strong\u003e Patients should be monitored for blurred vision and other ocular effects.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Nausea, vomiting, diarrhea, dizziness, and muscle pain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious:\u003c\/strong\u003e Allergic reactions, seizures, thromboembolic events, and potential renal impairment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eNote:\u003c\/strong\u003e This medication should be used under the supervision of a qualified healthcare provider. Always refer to the prescribing information for complete details.\u003c\/p\u003e\n\u003cp\u003eAs a trusted choice for healthcare professionals, Xgen Pharma's Tranexamic Acid Injection provides an effective solution for managing bleeding, ensuring optimal patient care and outcomes.\u003c\/p\u003e","brand":"Xgen Pharma","offers":[{"title":"Default Title","offer_id":39949552681032,"sku":"39822-1000-01","price":129.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Xgen-Tranexamic-Acid-_TXA_-for-Injection-100-mg-Single-Dose-Vial-10-mL.jpg?v=1683721407"},{"product_id":"tranexamic-acid-usp-for-compounding-api","title":"Tranexamic Acid API Powder USP For Customer Compounding (Rx)","description":"\u003ch1\u003eTranexamic Acid USP (API Powder)\u003c\/h1\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eTranexamic acid\u003c\/strong\u003e (TXA) is a synthetic analog of the amino acid lysine used as an antifibrinolytic agent. In its raw form (USP grade), it is a \u003cstrong\u003ewhite or nearly-white crystalline powder\u003c\/strong\u003e (CAS No. 1197-18-8). It is highly soluble in water and must be compounded (mixed with excipients) by a pharmacist to make dosage forms (tablets, injections, oral solutions). The “USP” designation means the powder meets United States Pharmacopeia standards for purity, strength and identity.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid API Pure Powder USP refers to the pure, active pharmaceutical ingredient (API) form of tranexamic acid that meets the quality and purity standards set by the United States Pharmacopeia (USP).\u003c\/p\u003e\n\u003ch3\u003eWhat is Tranexamic Acid?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTranexamic acid\u003c\/strong\u003e is a synthetic derivative of the amino acid lysine.\u003c\/li\u003e\n\u003cli\u003eIt is classified as an \u003cstrong\u003eantifibrinolytic agent\u003c\/strong\u003e, meaning it helps prevent the breakdown of blood clots.\u003c\/li\u003e\n\u003cli\u003eTranexamic acid inhibits the activation of plasminogen to plasmin, thereby reducing \u003cstrong\u003ebleeding\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eMechanism of Action\u003c\/h2\u003e\n\u003cp\u003eTranexamic acid works by \u003cstrong\u003einhibiting fibrinolysis\u003c\/strong\u003e. It reversibly binds to plasminogen’s lysine-binding sites, preventing its conversion to plasmin (the enzyme that degrades fibrin clots). In effect, TXA “stabilizes” formed clots and prevents excess bleeding. Unlike anticoagulants, it does not stop clot formation – it merely \u003cstrong\u003eslows clot breakdown\u003c\/strong\u003e, preserving native hemostatic clots. (At high concentrations it may also directly inhibit plasmin activity.) Pharmacologically, TXA is classified as an antifibrinolytic. By blocking plasmin(ogen), it reduces bleeding from mucosal surfaces and injury sites.\u003c\/p\u003e\n\u003ch2\u003ePharmacokinetics\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAbsorption:\u003c\/strong\u003e Orally, TXA is well-absorbed (bioavailability ~~33–50% in adults); peak blood levels occur in ~2–3 hours. It can be taken with or without food.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDistribution:\u003c\/strong\u003e It distributes into tissues and crosses the placenta; only small amounts enter breast milk (≈1% of maternal plasma levels).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolism\/Excretion:\u003c\/strong\u003e \u003cstrong\u003eAlmost no hepatic metabolism:\u003c\/strong\u003e TXA is eliminated primarily unchanged by the kidneys (glomerular filtration). About 90–95% of a dose is excreted in urine within 24 h (Because of this, \u003cstrong\u003edose reduction is required in renal impairment\u003c\/strong\u003e.) Minimal byproducts are formed, so it has low liver burden. Its plasma half-life is ~2–3 hours. (No special monitoring is needed usually, aside from renal function.)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eClinical Uses (Indications)\u003c\/h2\u003e\n\u003cp\u003eTranexamic acid is used \u003cstrong\u003eto treat or prevent excessive hemorrhage\u003c\/strong\u003e in a variety of settings. Key approved or customary uses include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMenorrhagia (Heavy Menstrual Bleeding):\u003c\/strong\u003e TXA tablets are FDA-indicated for cyclic heavy menstrual bleeding (menorrhagia) in women of reproductive age. A typical regimen is 1300 mg orally three times daily (3900 mg\/day) for up to 5 days each menstrual cycle. This reduces menstrual blood loss by stabilizing clots in the uterine lining.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eObstetric Bleeding (Postpartum Hemorrhage):\u003c\/strong\u003e TXA (1–2 g IV) is now widely used \u003cem\u003eoff-label\u003c\/em\u003e in postpartum hemorrhage (PPH). Early administration (ideally within 3 hours of delivery) significantly reduces maternal death from bleeding. The World Health Organization recommends early IV TXA in PPH. (The mountainside medical summary notes TXA is used to treat excessive bleeding in conditions like “postpartum hemorrhage”.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical\/Trauma Bleeding:\u003c\/strong\u003e Intraoperatively and in trauma, TXA (IV) is used to minimize blood loss. For example, in major orthopedic, cardiac and trauma surgeries, a 1 g IV dose (often followed by additional dosing) is common to reduce transfusions. The drug’s clot-stabilizing effect helps control surgical bleeding. (In acute trauma, the CRASH-2 trial showed that giving TXA within 3 hours reduced mortality.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHereditary Angioedema and Bleeding Disorders:\u003c\/strong\u003e TXA is used as an adjunct in hereditary angioedema to reduce bradykinin-mediated swelling, and in hemophilia or von Willebrand disease to control mucosal or surgical bleeding. For example, TXA mouthwashes or mouth tablets help prevent bleeding after tooth extraction in hemophilia.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDentistry\/Nosebleeds:\u003c\/strong\u003e A 4–5% TXA mouthwash or toner (e.g. soak gauze in solution) is used to control oral bleeding after dental procedures (especially in anticoagulated patients). It is also used as nasal spray (or soaked tampons) for refractory epistaxis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDermatology (Melasma):\u003c\/strong\u003e TXA has a beneficial effect in reducing melanin production. Orally or topically, it can help lighten melasma (brown facial spots) and other hyperpigmentation. (This use is off-label but increasingly common in dermatology.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOther:\u003c\/strong\u003e TXA may be used in GI bleeding, hematuria, and other hemorrhagic conditions, though evidence varies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eTXA is primarily indicated for \u003cstrong\u003ebleeding control\u003c\/strong\u003e: heavy menstrual bleeding and bleeding associated with surgery, trauma, or coagulopathies. (It is \u003cem\u003enot\u003c\/em\u003e used on its own to stop active clots, but to augment clot strength.) The US \u003cstrong\u003einjectable\u003c\/strong\u003e product is FDA-indicated for short-term use in hemophilia patients (before\/during dental extraction), but practitioners widely use the solution in other bleeding situations. Notably, TXA \u003cstrong\u003emust be prescribed\u003c\/strong\u003e – it is not available OTC. The API powder is only supplied to compounding pharmacies for use in prescription formulations.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eDosage Forms and Administration\u003c\/h2\u003e\n\u003cp\u003eTranexamic acid API powder is formulated into the following dosage forms:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eOral tablets\/capsules:\u003c\/strong\u003e Common strengths are 650 mg or 1000 mg (by combination). The usual oral dose for menorrhagia or other indications is 25–50 mg\/kg per day (up to ~3900 mg\/day) in divided doses (\u003ca data-statsig-event=\"api-link-clicked\" data-statsig-eventable=\"true\" data-underline=\"always\" class=\"kZ98Q\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=3f07e93b-3568-487e-894f-8f90e5a0960a#:~:text=,4%20mg%2FdL\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e). A typical adult regimen is 1300 mg PO TID for 3–5 days. For elderly or low body weight, adjust accordingly. Tablets should be swallowed whole.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIntravenous injection\/infusion:\u003c\/strong\u003e The standard IV form is 100 mg\/mL (10 mL vials of 1000 mg) (\u003ca data-statsig-event=\"api-link-clicked\" data-statsig-eventable=\"true\" data-underline=\"always\" class=\"kZ98Q\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=00630e54-0e84-465d-96a5-63486c87dcd9#:~:text=,dose%20vials.%20%283\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e). A common IV dose in acute bleeding is \u003cstrong\u003e1 gram\u003c\/strong\u003e, infused over 10 minutes. Dosing can be repeated once (for a total of 2 g) or given as a slow infusion (e.g. 1 g over 8 hours) depending on bleeding severity. For hemophilia (per label): 10 mg\/kg IV as one dose before a procedure, repeating 3–4 times daily for 2–8 days (\u003ca data-statsig-event=\"api-link-clicked\" data-statsig-eventable=\"true\" data-underline=\"always\" class=\"kZ98Q\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=00630e54-0e84-465d-96a5-63486c87dcd9#:~:text=,1%20mL%2Fminute%20to%20avoid%20hypotension\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e). (Doses \u0026gt;100 mg\/minute may cause hypotension.) ALWAYS ensure IV route – \u003cstrong\u003eNever give TXA intrathecally\u003c\/strong\u003e (it causes seizures (\u003ca data-statsig-event=\"api-link-clicked\" data-statsig-eventable=\"true\" data-underline=\"always\" class=\"kZ98Q\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=00630e54-0e84-465d-96a5-63486c87dcd9#:~:text=,%28%2029\" rel=\"noopener noreferrer\" target=\"_blank\"\u003edailymed.nlm.nih.gov\u003c\/a\u003e)).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTopical solutions:\u003c\/strong\u003e A 5–10% aqueous solution (e.g. 500 mg in 10 mL saline) can be applied locally (mouth rinse, soaked dressing) to control bleeding. This requires compounding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNasal spray:\u003c\/strong\u003e Commercial 10% TXA nasal sprays exist. (Compounded spray can be made from the powder in glycerin\/water.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePostpartum\/trauma protocols:\u003c\/strong\u003e In obstetrics or trauma, hospitals often stock 10 mL vials (1000 mg) of IV TXA. The protocol may be 1 g IV as soon as hemorrhage is diagnosed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eBecause TXA is primarily renally excreted, \u003cstrong\u003erenal dosing adjustments\u003c\/strong\u003e are required. For example, if serum creatinine \u0026gt;1.4 mg\/dL, reduce frequency (Menstrual bleeding regimen: see label). (Tablets: 1300 mg BID or daily instead of TID, per creatinine levels.) There are no dosage adjustments for mild hepatic impairment, as TXA is not metabolized by the liver.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eCompounding note: The API powder is used to make these formulations. It must be reconstituted and buffered properly (e.g. pH ~6–8) for injections. The final pH is usually slightly acidic. Practitioners should \u003cem\u003enot\u003c\/em\u003e attempt to dose the powder directly – it is for pharmacist use only\u003c\/span\u003e.\u003c\/p\u003e\n\u003ch2\u003eContraindications and Precautions\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eThromboembolic disease:\u003c\/strong\u003e TXA is \u003cstrong\u003econtraindicated\u003c\/strong\u003e in patients with active intravascular clotting or a history of thrombosis (DVT, PE, stroke). Do not use in patients with known hypercoagulable states. (TXA reduces clot breakdown, so it can worsen or precipitate thromboses.) Diabetics, smokers, or those on high-dose estrogen pills should use cautiously.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSubarachnoid hemorrhage:\u003c\/strong\u003e Contraindicated — TXA can cause cerebral edema and infarction in SAH. IV TXA is \u003cem\u003enot\u003c\/em\u003e used for head injury bleeds. (Meningeal irritation\/seizures can occur.)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Contraindicated if the patient has had an allergic reaction to TXA or its formulations. Tinctorial (skin) ingredients and parabens can also trigger allergy. Signs of anaphylaxis warrant immediate discontinuation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOcular factors:\u003c\/strong\u003e Use caution in patients with active retinal, ophthalmic vessel, or vitreous bleeding. (Retinal vein\/artery occlusion has been reported with TXA, especially in those on birth control.) If the patient experiences blurred vision or eye pain, TXA should be stopped and ophthalmology consulted.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy:\u003c\/strong\u003e \u003cem\u003eBefore delivery\u003c\/em\u003e, TXA tablets are \u003cstrong\u003enot indicated\u003c\/strong\u003e for use in pregnant women (no controlled studies exist). It crosses the placenta, so routine use in pregnancy is avoided except for life-threatening postpartum hemorrhage (after delivery). No teratogenic effects were seen in animal studies at clinical doses, but caution is advised.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBreastfeeding:\u003c\/strong\u003e TXA is excreted in breast milk (~1% of serum levels). The risk to the infant is presumed low, but a decision should consider the nursing benefits. If maternal TXA is needed (e.g. PPH control after birth), breastfeeding may be paused for 12–24 hours.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal impairment:\u003c\/strong\u003e Because TXA is renally cleared, reduce dose if creatinine is elevated (e.g. give 2g\/day instead of 4g, or extend interval). Monitor renal function in prolonged therapy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindicated drug interactions:\u003c\/strong\u003e Avoid concurrent use of TXA with blood-clotting factor concentrates (e.g. Factor IX complex or anti-inhibitor coagulant) or etretinate\/retinoids, as these combinations can severely increase thrombosis risk. Also, do not give TXA with systemic fibrinolytics (tPA, streptokinase) (they work oppositely). Concomitant hormonal contraceptives or high estrogen therapy may increase clot risk with TXA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute precautions:\u003c\/strong\u003e For the injection form, confirm IV route. Intrathecal\/spinal injection of TXA causes \u003cstrong\u003eseizures and neurotoxicity\u003c\/strong\u003e, so it must never be given into the epidural or spinal space. When administering an IV bolus, infuse slowly (over ≥10 min) to avoid hypotension.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSide effects:\u003c\/strong\u003e Common adverse effects are usually mild: gastrointestinal upset (nausea, diarrhea), headache, back or muscle pain, and fatigue. Less common are hypotension (if injected too fast), muscle cramps, vision changes, or allergic rash. Seizures can occur rarely at high IV doses (especially in renal failure) – this risk underlies the recommendation against neuraxial use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMonitoring:\u003c\/strong\u003e Generally no lab monitoring is required except renal function. Stop TXA if signs of thrombosis appear (leg swelling\/pain, chest pain, neurological deficits). If used for \u0026gt;5 days, monitor vision and blood counts (anemia\/fibrinogen not directly affected, but assess overall).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSpecial Populations and Tips\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGeriatrics:\u003c\/strong\u003e Avoid use in elderly unless clear indication, due to higher thrombotic risk. No dosage adjustment is specifically recommended besides renal dosing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePediatrics:\u003c\/strong\u003e TXA is used in children (e.g. congenital bleeding disorders, surgery) at weight-based doses (10–25 mg\/kg). Pharmacy should verify pediatric dosing.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCounseling and Nursing Tips:\u003c\/strong\u003e Explain that TXA is \u003cstrong\u003efor bleeding control\u003c\/strong\u003e, not a pain reliever. Advise patients that it may cause minor GI upset and to take with food if needed. Reinforce adherence to dosing times during heavy bleeding episodes. Educate women that TXA will not stop menstrual flow immediately but will reduce total blood loss.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcomitant Care:\u003c\/strong\u003e Treat underlying causes of bleeding concurrently (e.g. mechanical controls for PPH, iron supplementation for anemia, ect.). In PPH, TXA is an adjunct to uterotonics (oxytocin), uterine massage, and surgical interventions as needed. In menorrhagia, combine TXA with other management (hormonal therapy, iron therapy).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat Does \u003cstrong\u003eAPI Pure Powder\u003c\/strong\u003e Mean?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAPI (Active Pharmaceutical Ingredient):\u003c\/strong\u003e This is the primary, pharmacologically active compound used to make finished drugs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePure Powder:\u003c\/strong\u003e The raw, unformulated, highly purified powder (almost 100% tranexamic acid), suitable for pharmaceutical manufacturing.\u003c\/li\u003e\n\u003cli\u003eThis is \u003cstrong\u003enot the finished medicine\u003c\/strong\u003e but the raw material used to prepare medications (tablets, capsules, injections).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhat Does \u003cstrong\u003eUSP\u003c\/strong\u003e Mean?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eUSP\u003c\/strong\u003e stands for \u003cstrong\u003eUnited States Pharmacopeia\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIf a product is labeled \"USP,\" it \u003cstrong\u003emeets rigorous quality, purity, strength, and identity standards\u003c\/strong\u003e set by the USP.\u003c\/li\u003e\n\u003cli\u003eThis means the powder's chemical composition, potency, and absence of impurities have been verified according to USP specifications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eUses of Tranexamic Acid API Pure Powder USP\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eMaking prescription medications for:\n\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003eHeavy menstrual bleeding (menorrhagia)\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSurgical procedures\u003c\/strong\u003e to minimize blood loss\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHereditary angioedema\u003c\/strong\u003e and other rare bleeding disorders\u003c\/li\u003e\n\u003cli\u003eSometimes used topically or orally for \u003cstrong\u003emelasma\u003c\/strong\u003e (skin hyperpigmentation) in dermatology\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranexamic Acid USP for compounding is a medication used for the treatment or prevention of excessive bleeding or hemorrhage. It is commonly used during surgeries, dental procedures, and for heavy menstrual bleeding. Tranexamic Acid works by preventing the breakdown of blood clots, thereby reducing bleeding. It is also used as an antifibrinolytic agent to treat conditions such as hemophilia and von Willebrand disease. This medication is only available for compounding, which means it is not a commercially available product and must be prepared by a licensed pharmacist according to a specific formula prescribed by a healthcare provider. \u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic acid USP is an active pharmaceutical ingredient (API) used in prescription medications. It belongs to the class of drugs called antifibrinolytics, which work by preventing the breakdown of blood clots in the body.\u003cbr\u003e\u003cbr\u003eTranexamic acid USP is primarily used to prevent or treat excessive bleeding in patients with certain medical conditions, such as bleeding disorders, heavy menstrual bleeding, and postpartum hemorrhage. It is also used in dentistry and in surgeries to reduce bleeding.\u003cbr\u003e\u003cbr\u003eTranexamic acid USP is a synthetic form of the amino acid lysine and is available in various forms such as tablets, injections, and nasal sprays. It works by blocking the activity of plasmin, an enzyme responsible for breaking down blood clots. This helps to maintain normal blood clotting and control bleeding.\u003cbr\u003e\u003cbr\u003eAs an API, tranexamic acid USP is subject to strict quality control measures and must meet specific criteria for purity, strength, potency, and stability set by the USP. It is approved by the US Food and Drug Administration (FDA) and is considered safe and effective when used as directed by a healthcare professional.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCAS Number: 1197-18-8\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003eTranexamic acid USP powder is a potent antifibrinolytic API used to compound medications that prevent or treat bleeding. It is chemically a lysine analog that blocks plasmin and stabilizes clots. Clinically, TXA is invaluable in heavy menstrual bleeding, perioperative hemorrhage, and obstetric bleeding. Its shelf-life is long, but it must be formulated into patient-ready dosage forms. When using or prescribing TXA, clinicians should be aware of its dosing (e.g. 1300 mg PO TID in menorrhagia), renal elimination, and key contraindications (active clots, subarachnoid bleeding, allergies). Monitoring is straightforward, but nurses should observe for any signs of thrombosis or visual disturbance. By following dosing guidelines and precautions, TXA can markedly reduce bleeding without major systemic toxicity.\u003c\/span\u003e\u003c\/p\u003e","brand":"Mountainside Medical","offers":[{"title":"25 g","offer_id":40079709012040,"sku":"3211-04","price":139.0,"currency_code":"USD","in_stock":true},{"title":"50 g","offer_id":40079709044808,"sku":"3211-02","price":205.0,"currency_code":"USD","in_stock":true},{"title":"100 g","offer_id":40079709077576,"sku":"3211-05","price":325.0,"currency_code":"USD","in_stock":true},{"title":"500 g","offer_id":40079709110344,"sku":"3211-08","price":999.0,"currency_code":"USD","in_stock":true},{"title":"1 Kg","offer_id":40079709143112,"sku":"3211-09","price":1600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/TranexamicAcidUSPForCompounding_API.jpg?v=1729693444"},{"product_id":"tranexamic-acid-injection-1000-mg-per-10-ml-x-10-vials-rx","title":"Tranexamic Acid Injection 1000 mg Per 10 mL x 10 Vials (RX)","description":"\u003cp\u003eTranexamic Acid Injection 1000 mg is used to control or prevent excessive bleeding in medical conditions or surgical procedures. It works as an antifibrinolytic by inhibiting the breakdown of blood clots, thus reducing blood loss. Commonly used in surgeries, trauma cases, or heavy menstrual bleeding, it helps stabilize clots and promote hemostasis. It is vital in managing bleeding disorders and ensuring effective clotting, thereby enhancing recovery and patient outcomes.\u003c\/p\u003e\n\u003cp\u003eAvet Pharmaceuticals offers Tranexamic Acid Injection, a high-quality solution for managing and preventing excessive bleeding. With efficacy and reliability, this injection is an essential tool in clinical settings to support hemostasis during and after surgery or in cases of heavy menstrual bleeding.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 1000 mg per 10 mL vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 10 vials per box\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIndications:\u003c\/strong\u003e Used to reduce or prevent excessive bleeding\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Sterile, preservative-free solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufactured by Avet Pharmaceuticals:\u003c\/strong\u003e Adheres to stringent quality standards\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid is an antifibrinolytic agent that functions by inhibiting the activation of plasminogen to plasmin, an enzyme responsible for fibrin degradation. This mechanism helps stabilize blood clots and reduce hemorrhage, making it effective in treating conditions with abnormal bleeding.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e For intravenous use under the supervision of a healthcare professional.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDosage:\u003c\/strong\u003e Follow the prescribed dosage by the healthcare provider, tailored to the specific condition and patient needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Inspect the solution for particulate matter or discoloration before administration.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedical Supervision Required:\u003c\/strong\u003e Use only under the guidance of a qualified healthcare professional.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications:\u003c\/strong\u003e Not recommended for patients with active thrombosis or history of thromboembolic disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePregnancy and Nursing:\u003c\/strong\u003e Consult a physician before use if you are pregnant or breastfeeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInteractions:\u003c\/strong\u003e Ensure all medications being taken are known to the healthcare provider to prevent interactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCommon:\u003c\/strong\u003e Nausea, vomiting, or diarrhea.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSerious:\u003c\/strong\u003e Allergic reactions, vision changes, or signs of thrombosis; seek immediate medical attention if these occur.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiscontinue Use:\u003c\/strong\u003e If serious side effects develop, stop use and consult with a healthcare provider immediately.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTranexamic Acid Injection by Avet Pharmaceuticals is a trusted choice for controlling excessive bleeding. Always administer under the supervision of a healthcare professional to ensure safe and effective use tailored to your clinical needs. Trust Avet Pharmaceuticals for reliable and high-quality therapeutic solutions.\u003c\/p\u003e","brand":"Avet Pharmaceuticals","offers":[{"title":"Default Title","offer_id":52124623241584,"sku":"23155-0910-41","price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tranexamic-Acid-Injection-1000-mg-Avet-Pharmaceuticals.jpg?v=1742396167"},{"product_id":"tranexamic-acid-iv-bags-100-ml-infusion-therapy","title":"IV Bags Tranexamic Acid in 0.7% Sodium Chloride 1000 mg per 100 mL x 10\/Case","description":"Tranexamic Acid in 0.7% Sodium Chloride IV Bags is used to reduce or prevent excessive bleeding in various medical situations, such as during surgery, trauma, or in conditions like hemophilia. Tranexamic acid works by inhibiting the breakdown of blood clots, helping to stabilize and maintain clot formation to control bleeding.\n\u003cp\u003eTranexamic acid is a medication primarily used to treat or prevent excessive bleeding. It works by slowing the breakdown of blood clots, which helps control bleeding.\u003c\/p\u003e\n\u003cp\u003eIntroducing Tranexamic Acid in 0.7% Sodium Chloride IV Bags by Amneal Pharmaceuticals—an advanced solution for effective control of bleeding. Each 1000 mg per 100 mL IV bag is designed for rapid and efficient administration in clinical settings, ensuring reliable hemostatic support.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat It Is Used For:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid is used to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eReduce or prevent bleeding in patients with hemophilia during tooth extractions\u003c\/li\u003e\n\u003cli\u003eManage heavy menstrual bleeding\u003c\/li\u003e\n\u003cli\u003eControl bleeding in surgical procedures\u003c\/li\u003e\n\u003cli\u003eTreat hereditary angioedema attacks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDosage:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe recommended dosage for surgical bleeding is 10 mg\/kg IV, administered before surgery and repeated every 6 to 8 hours as needed. Dosage should be tailored to individual patient needs by healthcare professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCDC Guidelines:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe CDC highlights the importance of proper management of bleeding disorders with appropriate interventions. Tranexamic Acid should be used under healthcare supervision to ensure effective bleeding control.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDetails and Features:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConcentration:\u003c\/strong\u003e 1000 mg Tranexamic Acid per 100 mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePackaging:\u003c\/strong\u003e 10 IV bags per case\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Amneal Pharmaceuticals\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eQuality:\u003c\/strong\u003e High-grade formulation for clinical efficacy\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConvenience:\u003c\/strong\u003e Ready-to-use IV bags\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReliability:\u003c\/strong\u003e Trusted for consistent hemostatic support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid works by inhibiting fibrinolysis. It blocks the breakdown of fibrin clots by competitively inhibiting the activation of plasminogen to plasmin, helping to stabilize clots and reduce bleeding.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAdminister intravenously as directed by a healthcare provider.\u003c\/li\u003e\n\u003cli\u003eEnsure aseptic technique and monitor patient response during administration.\u003c\/li\u003e\n\u003cli\u003eFollow specific dosing instructions related to the type of bleeding being managed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUse caution in patients with a history of thromboembolic disease.\u003c\/li\u003e\n\u003cli\u003eNot recommended for patients with severe hypersensitivity to tranexamic acid.\u003c\/li\u003e\n\u003cli\u003eInform the healthcare provider of all medications being taken to avoid interactions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eSide Effects:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCommon side effects include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eDiarrhea\u003c\/li\u003e\n\u003cli\u003eDizziness\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSeek immediate medical help if you experience:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAllergic reactions (rash, swelling, difficulty breathing)\u003c\/li\u003e\n\u003cli\u003eVision changes\u003c\/li\u003e\n\u003cli\u003eSigns of a blood clot (pain, swelling, warmth in the limbs)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eConclusion:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTranexamic Acid in 0.7% Sodium Chloride IV Bags by Amneal Pharmaceuticals provides reliable support for managing bleeding effectively. Adhere to healthcare professional instructions for safe and successful administration.\u003c\/p\u003e","brand":"Amneal Pharmaceuticals","offers":[{"title":"Default Title","offer_id":52236073075056,"sku":"80830-2329-02","price":245.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tranexamic-Acid-IV-Bags-100-ml-by-Amneal.jpg?v=1746196126"},{"product_id":"tranexamic-acid-injection-1000-mg-per-10-ml-single-dose-vials-10-ml-x-10-box","title":"Tranexamic Acid Injection 1000 mg Per 10 mL Single-Dose Vials 10 mL x 10\/Box (RX)","description":"\u003cp\u003e\u003cstrong\u003ePowerful Hemostatic Solution for Bleeding Control\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eTranexamic Acid Injection 1000 mg per 10 mL by Caplin Steriles USA\u003c\/strong\u003e is a high-strength, hospital-grade antifibrinolytic agent designed for the effective treatment and prevention of severe bleeding. Used by healthcare providers everywhere, this life-saving injectable medication helps reduce and control blood loss during surgery, trauma, dental procedures, postpartum hemorrhage (PPH), and other acute bleeding events. Each box contains 10 sterile, single-dose 10 mL vials for accurate and immediate administration, making it an essential in every emergency room, surgical suite, and critical care setting.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eUses:\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTranexamic Acid Injection 1000 mg\/10 mL\u003c\/strong\u003e is widely used for:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMajor Surgery Bleeding Control:\u003c\/strong\u003e Cardiac, orthopedic (joint replacement, spinal), gynecological, urological, and dental surgery bleeding reduction.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrauma and Emergency Bleeding:\u003c\/strong\u003e First-line agent in severe trauma and accident cases to minimize blood loss and save lives.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePostpartum Hemorrhage (PPH):\u003c\/strong\u003e Critical use in obstetrics to prevent and treat heavy bleeding after childbirth, reducing maternal mortality.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMenorrhagia and Gynecological Bleeding:\u003c\/strong\u003e For acute, severe menstrual bleeding episodes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDental Procedures:\u003c\/strong\u003e Controls excessive bleeding in patients with bleeding disorders or during tooth extractions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHereditary and Acquired Bleeding Disorders:\u003c\/strong\u003e Such as hemophilia or thrombocytopenia (per medical guidance).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eFeatures and Health Benefits:\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePowerful Hemostatic Agent:\u003c\/strong\u003e Tranexamic Acid (TXA) works by inhibiting fibrinolysis, stabilizing blood clots, and significantly reducing acute bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical-Grade Dosing:\u003c\/strong\u003e Each 10 mL vial contains 1000 mg, providing rapid results for trauma, surgery, postpartum hemorrhage, and dental bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEssential for Emergency Medicine:\u003c\/strong\u003e Used in trauma protocols, major surgery, and obstetrics (PPH) to control life-threatening bleeding and improve patient outcomes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFlexible Administration:\u003c\/strong\u003e Can be given via IV (intravenous) infusion, IV bolus, or IM (intramuscular) injection depending on clinical needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved and GMP Certified:\u003c\/strong\u003e Manufactured in the USA by Caplin Steriles for maximum purity, safety, and efficacy.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReady-to-Use, Single-Dose Vials:\u003c\/strong\u003e 10 mL sterile vials ensure accurate dosing, sterility, and convenience for urgent care environments.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven in Clinical Practice:\u003c\/strong\u003e Supported by landmark protocols in trauma (CRASH-2, WOMAN trial), surgery, and emergency care for bleeding disorders.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReduces Need for Blood Transfusion:\u003c\/strong\u003e An effective option to manage and prevent excessive blood loss without reliance on donor blood.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSafe, Well-Tolerated, and Trusted Worldwide:\u003c\/strong\u003e Low risk of adverse effects when used as directed; standard of care in hospitals globally.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose Caplin Steriles USA Tranexamic Acid Injection?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted Brand:\u003c\/strong\u003e Manufactured by Caplin Steriles, a leader in quality pharmaceuticals for hospital and emergency use.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHighest Clinical Standards:\u003c\/strong\u003e FDA-approved, GMP compliant for safety and performance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUsed in Top US Hospitals:\u003c\/strong\u003e Preferred by surgeons, trauma centers, emergency physicians, and OB\/GYN specialists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBacked by Global Guidelines:\u003c\/strong\u003e Recommended in the World Health Organization (WHO), American College of Surgeons, ACOG, and hematology practice guidelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsistent, Reliable Results:\u003c\/strong\u003e Ensure optimal hemostasis when seconds matter most.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eFrequently Asked Questions (FAQs)\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is Tranexamic Acid Injection safe?\u003c\/strong\u003e \u003cem\u003eA: Tranexamic acid is well-tolerated when administered by a healthcare professional for approved indications. Side effects are rare and typically mild, but all medications should be used with appropriate monitoring.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How is Tranexamic Acid administered?\u003c\/strong\u003e \u003cem\u003eA: Can be given intravenously or intramuscularly as a single dose or divided doses, depending on clinical scenario. Dosage will be determined by a healthcare provider.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What are the most common uses for Tranexamic Acid?\u003c\/strong\u003e \u003cem\u003eA: Surgical bleeding, trauma\/accident-related hemorrhage, postpartum hemorrhage (PPH), severe menstrual bleeding, and dental procedures with bleeding risk.\u003c\/em\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Does this require a prescription?\u003c\/strong\u003e \u003cem\u003eA: Yes. Tranexamic acid injection is a prescription medication and should only be used under direct medical supervision.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003eProper Use and Safety Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFor Hospital\/Healthcare Provider Use Only:\u003c\/strong\u003e Not intended for home or self-administration.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAlways follow institutional guidelines for dosing and monitoring.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMonitor for allergies or rare thrombotic complications in at-risk patients.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eStore at controlled room temperature and avoid freezing.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eOrder Tranexamic Acid Injection 1000 mg per 10 mL Single-Dose Vials (10 x 10 mL\/Box) by Caplin Steriles USA – Trusted Bleeding Control for Surgery, Trauma, and Emergency Care\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eTranexamic Acid Injection 1000 mg\/10 mL by Caplin Steriles USA\u003c\/strong\u003e is your frontline solution for rapid, reliable control of acute bleeding in surgical, trauma, and obstetric settings. Protect patient lives, minimize transfusions, and ensure the highest standard of care in every critical situation.\u003c\/p\u003e","brand":"Caplin Steriles USA","offers":[{"title":"Default Title","offer_id":52687498084720,"sku":"65145-0106-10","price":48.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tranexamic-Acid-Injection-1000-mg-Caplin-Steriles-65145-0106-10.jpg?v=1763134778"},{"product_id":"tranexamic-acid-650mg-tablets-usp-by-advagen-pharma-30-count-rx","title":"Tranexamic Acid 650mg Tablets USP by Advagen Pharma 30 Count (RX)","description":"\u003cp\u003eTake control of your health with Tranexamic Acid 650mg Tablets by Advagen Pharma, expertly formulated to support those experiencing excessive bleeding. This premium product offers effective relief, empowering you to live with confidence and comfort.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eKey Benefits and Uses:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eControl Heavy Menstrual Bleeding:\u003c\/strong\u003e Specially designed to treat menorrhagia, Tranexamic Acid significantly reduces heavy menstrual flow.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImprove Surgical Recovery:\u003c\/strong\u003e Plays a crucial role in minimizing bleeding during and after surgical procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eHow It Works:\u003c\/strong\u003e Tranexamic Acid works by inhibiting the breakdown of fibrin clots, effectively slowing down bleeding. It targets plasminogen activation, ensuring that clots remain intact to reduce excessive blood loss.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eBest Practices for Use:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsult Your Healthcare Provider:\u003c\/strong\u003e Ensure the treatment aligns with your health needs by discussing with your doctor.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdhere to Prescribed Dosage:\u003c\/strong\u003e Typically taken two to three times daily during the period of heavy bleeding.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRegular Monitoring:\u003c\/strong\u003e Track your symptoms to adjust treatment as needed under medical supervision.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRelated RX Products:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eLysteda:\u003c\/strong\u003e Another option for managing heavy menstrual bleeding with similar active ingredients.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCyklokapron:\u003c\/strong\u003e Often used in surgical settings to control bleeding.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003ePossible Side Effects:\u003c\/strong\u003e While generally well-tolerated, Tranexamic Acid may cause:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNausea\u003c\/li\u003e\n\u003cli\u003eDiarrhea\u003c\/li\u003e\n\u003cli\u003eHeadache\u003c\/li\u003e\n\u003cli\u003eBack pain\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eSeek medical advice if you experience symptoms of a severe allergic reaction or vision changes.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eNDC:\u003c\/strong\u003e 72888-0178-30 \u003cstrong\u003eUPC:\u003c\/strong\u003e 372888178301\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTop Health Keywords:\u003c\/strong\u003e heavy menstrual bleeding, menorrhagia treatment, surgical bleeding, clot prevention, fibrin stabilization, hemostasis control, Tranexamic Acid benefits, Advagen Pharma, Lysteda alternative, Cyklokapron equivalent, prescription medication.\u003c\/p\u003e\n\u003cp\u003eHarness the power of Tranexamic Acid 650mg Tablets by Advagen Pharma for effective management of excessive bleeding. Prioritize your health and well-being today.\u003c\/p\u003e","brand":"Advagen Pharma","offers":[{"title":"Default Title","offer_id":53203635372400,"sku":"72888-0178-30","price":58.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Tranexamic-Acid-650mg-Tablets--USP-by-Advagen-Pharma.jpg?v=1769268843"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/Tranexamic_Acid_TXA_Injections.jpg?v=1775656662","url":"https:\/\/www.mountainside-medical.com\/collections\/tranexamic-acid-injection-control-heavy-bleeding.oembed?constraint=tranexamic-acid","provider":"Mountainside Medical","version":"1.0","type":"link"}